Alector, Inc. (ALEC) Stock Grade

About Alector, Inc.'s fundamentals

Alector, Inc. is a biotechnology company with a market capitalization of $160.7 million that reported a significant net loss in its latest annual statement, resulting in a net margin of -679.2%. The company experienced a substantial revenue decline of 79.1% year-over-year, indicating a sharp contraction in its commercial operations. With no dividend yield and negative profitability metrics, the company is not currently generating positive returns for shareholders.